Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 8, 2007, Pages 958-961

  Calderon, M A ^a   Birk, A O ^b   Andersen, J S ^b   Durham, S R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ALK ABELLÓ   (Denmark)

Author keywords

Efficacy; Grass; Immunotherapy; Preseasonal treatment period; Sublingual

Indexed keywords

ALLERGEN; GRAZAX; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCULATION; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; CORRELATION FUNCTION; DATA ANALYSIS; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SYMPTOM; TREATMENT DURATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; POACEAE; RHINITIS, ALLERGIC, SEASONAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 34447121362     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01416.x     Document Type: Article

References (10)

1. Passalacqua G, Canonica GW. Sublingual or injection immunotherapy: the final answer? Allergy 2004 59 : 37 38.
2. Passalacqua G, Lombardi C, Canonica GW. Sublingual immunotherapy: an update. Curr Opin Allergy Clin Immunol 2004 4 : 31 36.
3. Wilson DR, Torres LM, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60 : 4 12.
4. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003 111 : 437 448.
5. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual once-daily grass-pollen immunotherapy: a randomised controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 117 : 802 809.
6. Dahl R, Stender A, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006 61 : 185 190.
7. Dahl R, Kapp A, Colombo G., de Monchy J, Rak S, Emminger W et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablet for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 118 : 434 440.
8. Malling H-J, Lund L, Ipsen H, Poulsen LK. Safety and immunological changes during specific sublingual immunotherapy with SQ standardized grass allergen tablets. J Investig Allergol Clin Immunol 2006 16 : 162 168.
9. Kleine-Tebbe J, Ribel M, Herold DA. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 2006 61 : 181 184.
10. Frew AJ, Powell RJ, Corrigan CJ, Durham SR. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 117 : 319 325.